Concepedia

Publication | Open Access

Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)

DOIFull Paper Access

14

Citations

0

References

2019

Year

Lorenza Rimassa, Robin Kate Kelley, Tim Meyer, Baek‐Yeol Ryoo, Philippe Merle, J.-W. Park, Jean‐Frédéric Blanc, Ho Yeong Lim, Albert Tran, Anne E. Borgman-Hagey,
Annals of Oncology

No additional data available for this publication yet. Check back later!